Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Using MRI to assess fertility-sparing treatment for cervical cancer

Official title: Role of MRI Assessment in Fertility Sparing Treatment for Cervical Cancer at Staging and Follow-up and for Identification of Risk Factors for Aggressive Disease.

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06877065 · Data updated 2026-11-12

This study is testing how MRI can help women with early-stage cervical cancer who want to keep their ability to have children, by checking how well their fertility-sparing treatments are working.

More Cervical Cancer trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment60 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Rome)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2028
Registry record updatedMarch 14, 2025
Trial IDNCT06877065 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women with early-stage cervical cancer (FIGO stage IB1-IIA1) who wish to preserve their fertility and have undergone MRI imaging.

Probably not a fit

Patients under 18 years, those with rare histologies of cervical cancer, or those currently pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the role of MRI, including diffusion-weighted imaging (DWI), in staging and evaluating the response to fertility-sparing treatments for early-stage cervical cancer. It focuses on patients desiring to preserve their fertility while undergoing treatments such as radical trachelectomy or cold knife conization. The study aims to identify risk factors for aggressive disease and assess the effectiveness of these treatments through pre- and post-treatment MRI evaluations. The research is conducted at the Oncological Gynecology Unit of Fondazione Policlinico Universitario Agostino Gemelli.

Why it matters

Potential benefit: If successful, this study could improve the management of cervical cancer in young women wishing to maintain their fertility.

How similar studies have gone: While the approach of using MRI in this context is gaining attention, the specific application in fertility-sparing treatments for cervical cancer is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with cervical cancer FIGO stage up to IB2-IIA1 (T size \< 4 cm) wishing to preserve fertility treated at the Oncological Gynecology Unit of Foundation Policlinico Universitario Agostino Gemelli.
* absence of nodal disease,
* no menopausal status
* wish to preserve fertility
* refusal of radical treatment.
* Patients who had a pre-treatment and post-treatment magnetic resonance imaging.
* Availability of digital MR images and histopathological samples.

Exclusion Criteria:

* Patients aged under 18 years.
* Neuroendocrine cervical tumours or other rare histology, such as glassy cells or clear cell carcinoma non-HPV related adenocarcinoma.
* ongoing pregnancy at the time of diagnosis.
* Patients without available MR images on digital media or with low quality images.

Where it's running

  • Advanced Radiology Center- Fondazione Policlinico Universitario A. Gemelli IRCCS
    Rome, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.